Chugai Seiyaku Kabushiki Kaisha

Juridical Foundation the Chemo-Sero-Therapeutic Research Institute

Kazuyuki Yoshizaki

Norihiro Nishimoto

Hiroaki Ito

Tadamitsu Kishimoto

Hidetomo Kitamura

Masamichi Sugimoto

Kenichi Akamatsu

Shin Shimaoka

Shumpei Yokota

Takako Miyamae

Masahiro Iwamoto

Seiji Minota

Toshihiro Nakashima

Kazuhisa Sugimura

Takumi Sasaki

A therapeutic agent for chronic arthritides diseases of childhood-related diseases, for example chronic arthritides diseases of childhood, Still's disease and the like, comprising an interleukin-6 (IL-6) antagonist as an active ingredient.

Therapeutic agent for chronic arthritides diseases of childhood-related diseases

A method for treating psoriasis comprising an interleukin-6 (IL-6) antagonist such as, for example, an antibody against IL-6 receptor.

Method for treating psoriasis by administering an antibody to interleukin-6 receptor

A method for treating psoriatic arthritis comprising an interleukin-6 (IL-6) antagonist such as, for example, an antibody against IL-6 receptor.

Method of treating psoriatic arthritis with an IL-6 receptor antibody

A blood vascular endothelial growth factor (VEGF) level-lowering agent comprising an interleukin-6 (IL-6) antagonist as an active ingredient.

Blood VEGF level-lowering agent containing IL-6 antagonist as the active ingredient

A substance effective for treating immunopathy where interleukin 6 (IL-6) is involved is provided. A human anti-human IL-6 antibody and a human anti-human IL-6 antibody fragment having a high affinity to human IL-6 were obtained using phage antibody technique. The antibody and antibody fragment are expected to be useful as a medicament for treating inflammation and immunopathy caused by IL-6.

Human antihuman interleukin-6 antibody and fragment of antibody

A preventive and therapeutic agent for psoriasis comprising an interleukin-6 (IL-6) antagonist such as, for example, an antibody against IL-6 receptor.

Growing community of inventors

Ashiya, Japan

Kazuyuki Yoshizaki